glp 1 tirzepatide vs semaglutide vs. Semaglutide: What You Should Know Tirzepatide vs Semaglutide for Microdosing

Supports Weight Management Aids in long-term weight loss when used consistently

Blocks glucagon: GLP-1 suppresses glucagon secretion, which is a hormone that increases blood sugar

Future availability would depend on licensing, clinical guidance, and whether higher-dose tablets offer enough benefit compared with existing treatments

Head over to our product page to see what your options are

Recent expert consensus from 20232025 characterizes these medications as metabolic disease modifiers rather than simple glucose lowering agents

2 The MHRA approved the Wegovy pill in the UK on 11 June 2026, making it the first GLP-1 weight-loss tablet licensed in the country